Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Current Deferred Revenue: 2015-2025

Historic Current Deferred Revenue for BIO-TECHNE (TECH) over the last 11 years, with Jun 2025 value amounting to $35.3 million.

  • BIO-TECHNE's Current Deferred Revenue rose 11.99% to $32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year increase of 11.99%. This contributed to the annual value of $35.3 million for FY2025, which is 16.89% up from last year.
  • Latest data reveals that BIO-TECHNE reported Current Deferred Revenue of $35.3 million as of FY2025, which was up 16.89% from $30.2 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Current Deferred Revenue registered a high of $35.3 million during FY2025, and its lowest value of $20.0 million during FY2021.
  • Its 3-year average for Current Deferred Revenue is $30.0 million, with a median of $30.2 million in 2024.
  • As far as peak fluctuations go, BIO-TECHNE's Current Deferred Revenue surged by 40.85% in 2021, and later declined by 3.53% in 2023.
  • Over the past 5 years, BIO-TECHNE's Current Deferred Revenue (Yearly) stood at $20.0 million in 2021, then grew by 27.50% to $25.5 million in 2022, then fell by 3.53% to $24.6 million in 2023, then grew by 22.76% to $30.2 million in 2024, then climbed by 16.89% to $35.3 million in 2025.